Aouatef earned her PhD in Toxicology with honors in the field of cytochrome P450 metabolism at Sorbonne University. She joined ADM in January 2022, with 10 years of experience in R&D and innovation for nutrition, dietary supplements, and clinical development at Lonza. Prior, she spent 7 years at Bristol-Myers Squibb in the metabolic disease department. Aouatef is the author of over 40 peer reviewed articles and owner of 10 patents.